Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roser Torra

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2024
Kidney health matters: a global imperative for public healthRoser Torra
Medicina Clinica|November 20, 2013
[Treatment of autosomal dominant polycystic kidney disease]Roser Torra
F1000Research|February 14, 2019
Recent advances in the clinical management of autosomal dominant polycystic kidney diseaseRoser Torra
Kidney International. Supplement|November 29, 2008
Renal manifestations in Fabry disease and therapeutic optionsRoser Torra
Nutrients|November 11, 2022
Dietary Aspects and Drug-Related Side Effects in Autosomal Dominant Polycystic Kidney Disease ProgressionBorja Quiroga, Roser Torra
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 14, 2019
New therapeutic options for Alport syndromeRoser Torra, Mónica Furlano
Clinical Kidney Journal|October 6, 2017
Rare diseases, rare presentations: recognizing atypical inherited kidney disease phenotypes in the age of genomicsElisabet Ars, Roser Torra
Medicina Clinica|September 19, 2017
Erratum to «Recommendations for the multidisciplinary management of tuberous sclerosis complex» [MedClin(Barc)147(5) (2016) 211-216]Alfons Macaya, Roser Torra,
Clinical Kidney Journal|May 29, 2015
Fabry disease: the many faces of a single disorderRoser Torra, Alberto Ortíz
Medicina Clinica|May 23, 2016
[Recommendations for the multidisciplinary management of tuberous sclerosis complex]Alfons Macaya, Roser Torra,
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2024
Kidney health matters: a global imperative for public healthRoser Torra
Medicina Clinica|November 20, 2013
[Treatment of autosomal dominant polycystic kidney disease]Roser Torra
F1000Research|February 14, 2019
Recent advances in the clinical management of autosomal dominant polycystic kidney diseaseRoser Torra
Kidney International. Supplement|November 29, 2008
Renal manifestations in Fabry disease and therapeutic optionsRoser Torra
Nutrients|November 11, 2022
Dietary Aspects and Drug-Related Side Effects in Autosomal Dominant Polycystic Kidney Disease ProgressionBorja Quiroga, Roser Torra
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 14, 2019
New therapeutic options for Alport syndromeRoser Torra, Mónica Furlano
Clinical Kidney Journal|October 6, 2017
Rare diseases, rare presentations: recognizing atypical inherited kidney disease phenotypes in the age of genomicsElisabet Ars, Roser Torra
Medicina Clinica|September 19, 2017
Erratum to «Recommendations for the multidisciplinary management of tuberous sclerosis complex» [MedClin(Barc)147(5) (2016) 211-216]Alfons Macaya, Roser Torra,
Clinical Kidney Journal|May 29, 2015
Fabry disease: the many faces of a single disorderRoser Torra, Alberto Ortíz
Medicina Clinica|May 23, 2016
[Recommendations for the multidisciplinary management of tuberous sclerosis complex]Alfons Macaya, Roser Torra,
Pageof 17